Inclusion Criteria : 
  -  Patients must be ≥ 3 and ≤ 18 years of age. 
  -  The predicted survival period is more than 3 months. 
  -  According to RECIST version 1.1 , there is at least one measurable lesion. 
  -  Post -  - operative pathological stage was group II - IV. 
  -  Patients have not received radiotherapy before , and can accept chemotherapy and surgical treatment. 
  -  No other anticancer therapy should be used during radiotherapy. 
  -  The main organs are functioning normally , which meets the following criteria : 
       1.  Blood routine examination standards should be met : ( no blood transfusion within 14 days ) A.  HB > 90 g / L; B.  ANC > 1.5 * 109 / L; C.  PLT > 80 * 109 / L
       2.  Biochemical tests should meet the following criteria : 
A.  BIL < 1.25 times normal upper limit ( ULN ) ; B.  ALT and AST < 2.5 ULN; C.  Serum Cr < 1 ULN , endogenous creatinine clearance > 50 ml / min
  -  Subjects volunteered to participate in this study , patients or legal guardians signed informed consent through patient consent , good compliance , with follow - up. 
  -  Doctors believe that treatment can benefit patients. 
